Author:
Pfaller Michael A.,Castanheira Mariana,Messer Shawn A.,Rhomberg Paul R.,Jones Ronald N.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference40 articles.
1. EUCAST and CLSI: how to assess in vitro susceptibility and clinical resistance;Alastruey-Izquierdo;Curr Fungal Infect Rep,2012
2. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media;Arendrup;Antimicrob Agents Chemother,2010
3. Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots;Arendrup;Antimicrob Agents Chemother,2011
4. EUCAST Technical Note on the EUCAST definitive document EDef 7.2: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST);Arendrup;Clin Microbiol Infect,2012
5. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme;Arendrup;Clin Microbiol Infect,2013